GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » EV-to-EBITDA

Aptorum Group (Aptorum Group) EV-to-EBITDA : -2.14 (As of Apr. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aptorum Group's enterprise value is $30.58 Mil. Aptorum Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-14.30 Mil. Therefore, Aptorum Group's EV-to-EBITDA for today is -2.14.

The historical rank and industry rank for Aptorum Group's EV-to-EBITDA or its related term are showing as below:

APM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -89.84   Med: -1.19   Max: 13.82
Current: -2.14

During the past 6 years, the highest EV-to-EBITDA of Aptorum Group was 13.82. The lowest was -89.84. And the median was -1.19.

APM's EV-to-EBITDA is ranked worse than
100% of 473 companies
in the Biotechnology industry
Industry Median: 9.22 vs APM: -2.14

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), Aptorum Group's stock price is $5.48. Aptorum Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.650. Therefore, Aptorum Group's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Aptorum Group EV-to-EBITDA Historical Data

The historical data trend for Aptorum Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group EV-to-EBITDA Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial -43.70 -30.36 7.87 -1.52 -1.02

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.52 - -1.02 -

Competitive Comparison of Aptorum Group's EV-to-EBITDA

For the Biotechnology subindustry, Aptorum Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptorum Group's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aptorum Group's EV-to-EBITDA falls into.



Aptorum Group EV-to-EBITDA Calculation

Aptorum Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=30.583/-14.301
=-2.14

Aptorum Group's current Enterprise Value is $30.58 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptorum Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-14.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptorum Group  (NAS:APM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Aptorum Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.48/-3.650
=At Loss

Aptorum Group's share price for today is $5.48.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptorum Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.650.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Aptorum Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Aptorum Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group (Aptorum Group) Business Description

Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group (Aptorum Group) Headlines